From: "ieffrey E." <ieeyacation(agmail.com> To: Subject: Re: From wikipedia... Date: Mon, 19 Jun 2017 08:09:18 +0000 Are the ears - Flowers. Wax coating small hairs On Mon, Jun 19, 2017 at 2:12 Als wrote: I went through this list of protein aggregation diseases or proteopathies ... or what I'm calling aggregopathies. It's not a problem with the protein, it's a problem be they aggregate. Anyway, I just did a basic search of all of the names and checked to see if there was evidence for change in intracellular PH with all...yup/not all are in neurons. Weird = this is what happens when you acidify the soil. Proteopathy Major aggregating protein Alzheimer's diseaset161 Amyloid p peptide (Ap); Tau protein (see tauopathies) Cerebral p-amyloid angiopathrl Amyloid p peptide (Ap) Retinal ganglion cell degeneration in glaucomat501 Amyloid p peptide (Ap) Prion diseases (multiple)t511 Prion protein Parkinson's disease and other synucleinopathies (multiple)15~1 a-Synuclein Tauopathies (multiple)1531 Microtubule-associated protein tau (Tau protein) Frontotemporal lobar degeneration (FTLD) (Ubi+, Tau-)154I TDP-43 FTLD-FUSt541 Fused in sarcoma (FUS) protein Amyotrophic lateral sclerosis (ALS)[551(561 Superoxide dismutase, TDP-43, FUS, C9ORF72, ubiquilin-2 (UBQLN2) Huntington's disease and other trinucleotide repeat disorders (multiple)151t581 Proteins with tandem glutamine expansions Familial British dementia[491 ABri Familial Danish dementia(491 ADan Hereditary cerebral hemorrhage with amyloidosis (Icelandic) (HCHWA-I)1491 Cystatin C CADASILI591 Notch3 Alexander diseaserq Glial fibrillary acidic protein (GFAP) Seipinopathiest611 Seipin Familial amyloidotic neuropathy, Senile systemic amyloidosis Transthyretin 2 [6 1 Serpinopathies (multiple)ts3l Serpins AL (light chain) amyloidosis (primary systemic amyloidosis ) Monoclonal immunoglobulin light chains(621 EFTA01043156 AH (heavy chain) amyloidosis Immunoglobulin heavy chains(62] AA (secondary) amyloidosis Amyloid A protein1621 Type II diabetes[641 Islet amyloid polypeptide (IAPP; amylin) Aortic medial amyloidosis Medin (lactadherin)(621 ApoAl amyloidosis Apolipoprotein Al[621 ApoAll amyloidosis Apolipoprotein All[621 ApoAlV amyloidosis Apolipoprotein AlVi621 Familial amyloidosis of the Finnish type (FAF) Gelsolin16~1 Lysozyme amyloidosis Lysozymel6~1 Fibrinogen amyloidosis Fibrinogenl6~1 Dialysis amyloidosis Beta-2 microglobulinl6~1 Inclusion body myositis/myopathy[651 Amyloid p peptide (An) Cataractsisq Crystallins Retinitis pigmentosa with rhodopsin mutations[671 rhodopsin Medullary thyroid carcinoma Calcitonin1621 Cardiac atrial amyloidosis Atrial natriuretic factor[621 Pituitary prolactinoma Prolactin1621 Hereditary lattice comeal dystrophy Keratoepithelin[621 Cutaneous lichen amyloidosis(681 Keratins Mallory bodies(691 Keratin intermediate filament proteins Corneal lactoferrin amyloidosis Lactoferrin1621 Pulmonary alveolar proteinosis Surfactant protein C (SP-C)1621 Odontogenic (Pindborg) tumor amyloid Odontogenic ameloblast-associated protein1621 Seminal vesicle amyloid Semenog din 11621 Apolipoprotein C2 amyloidosis Apolipoprotein C2 (ApoC2)1621 Apolipoprotein C3 amyloidosis Apolipoprotein C3 (ApoC3)1621 Lect2 amyloidosis Leukocyte chemotactic factor-2 (Lect2)1621 Insulin amyloidosis Insulin1621 Galectin-7 amyloidosis (primary localized cutaneous amyloidosis) Galectin-7 (Ga17)t6~1 Corneodesmosin amyloidosis Comeodesmosin[621 Enfuvirtide amyloidosisRi Enfuvirtide1621 Cystic Fibrosis cystic fibrosis transmembrane conductance regulator (CFTR) protein Sickle cell diseasel7~1 Hemoglobin please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this EFTA01043157 communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to jeevacation@gmail.com, and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA01043158